Cargando…
Variables and Strategies in Development of Therapeutic Post-Transcriptional Gene Silencing Agents
Post-transcriptional gene silencing (PTGS) agents such as ribozymes, RNAi and antisense have substantial potential for gene therapy of human retinal degenerations. These technologies are used to knockdown a specific target RNA and its cognate protein. The disease target mRNA may be a mutant mRNA cau...
Autores principales: | Sullivan, Jack M., Yau, Edwin H., Kolniak, Tiffany A., Sheflin, Lowell G., Taggart, R. Thomas, Abdelmaksoud, Heba E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138052/ https://www.ncbi.nlm.nih.gov/pubmed/21785698 http://dx.doi.org/10.1155/2011/531380 |
Ejemplares similares
-
Systematic Screening, Rational Development, and Initial Optimization of Efficacious RNA Silencing Agents for Human Rod Opsin Therapeutics
por: Yau, Edwin H., et al.
Publicado: (2019) -
Traffic into silence: endomembranes and post-transcriptional RNA silencing
por: Kim, Yun Ju, et al.
Publicado: (2014) -
Virus-Induced Gene Silencing, a Post Transcriptional Gene Silencing Method
por: Unver, Turgay, et al.
Publicado: (2009) -
A conserved mechanism for post-transcriptional gene silencing?
por: Maine, Eleanor M
Publicado: (2000) -
WDHD1 modulates the post-transcriptional step of the centromeric silencing pathway
por: Hsieh, Chia-Ling, et al.
Publicado: (2011)